Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 23;23(5):54.
doi: 10.1007/s11912-021-01048-4.

Rare Breast Cancer Subtypes

Sarah Jenkins #  1   2 , Megan E Kachur #  3 , Kamil Rechache #  2 , Justin M Wells #  4 , Stanley Lipkowitz  5
Affiliations
Review

Rare Breast Cancer Subtypes

Sarah Jenkins et al. Curr Oncol Rep. .

Abstract

Purpose of review: Breast cancer is a collection of diseases including the more common invasive ductal and lobular carcinomas and rarer subtypes of breast cancer. This review summarizes the features of rare breast cancers.

Recent findings: Each of the rare tumors has defined pathological and clinical features that impact treatment recommendations. In this review, we summarize these for each rare type of breast cancer and where available we include molecular features of each tumor. Rare subtypes of breast cancer each have unique features. In many cases, data is limited for the optimal treatment approaches.

Keywords: Breast cancer; Rare breast cancer subtypes.

PubMed Disclaimer

References

    1. Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 2005;23(29):7350–60. - PubMed
    1. Sharpiro C, Barsky SH. Infiltrating carcinomas of the breast: Not one disease. In: Bland KI, Copeland, editors. The Breast: Comprehensive management of benign and malignant disease. 1. Philadelphia, PA: Saunders Elsevier; 2009. p. 231–47.

    1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869–74.

      This landmark paper identified molecular subtypes of breast cancer including luminal A, luminal B, basal and HER2 enriched based on the gene expression patterns, and is the basis for preclinical and clinical trial approaches to breast cancer.

    1. WHO Classification of Tumours Editorial Board. Breast Tumours: World Health Organization classification of tumours. 5th ed. Lyon, France: IARC Press; 2019.

      The WHO classification of breast cancer is the reference for all pathology analysis and classification.

    1. Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat. 2008;111(3):541–7. - PubMed

Publication types